ARRALYZE Partners with NewCellX for Distribution in France
What This Means for French Researchers?
France is home to a dynamic biotechnology and life sciences community, ranging from academic research groups to pharmaceutical companies and biotech startups. Through this collaboration, these institutions will now have easier access to advanced single cell technologies, including gentle dispensing, real-time imaging, AI-supported analysis, and precise isolation.
NewCellX brings local expertise in laboratory instruments and consumables, along with dedicated customer support. Their services include consultation, installation, user training, and ongoing maintenance, ensuring researchers can smoothly integrate the CellShepherd® into their existing workflows.
Applications and Target Users
The partnership aims to support a wide range of applications such as cell line development, monoclonal antibody discovery, CAR-T therapy, synthetic biology, and drug discovery. By combining ARRALYZE’s technology with NewCellX’s local presence, French laboratories will benefit from both advanced single cell tools and direct, on-the-ground support.
Getting Started
Laboratories interested in the CellShepherd® system can contact NewCellX directly at contact@newcellx.fr for technical discussions, demonstrations, or pricing information. NewCellX will also showcase the technology at relevant French life sciences conferences and trade shows.
This distribution agreement is part of ARRALYZE's broader strategy to expand access to single cell analysis technology through regional partners who understand local market needs and regulatory requirements.
ARRALYZE looks forward to working with NewCellX to strengthen single cell research in France.
Further Information
